In a move aimed at strengthening its portfolio of services, Ginkgo Bioworks announced this week that it has acquired three startups: gene-editing diagnostics developer Proof Diagnostics, artificial intelligence (AI)-driven drug discovery company Reverie Labs, and AI platform developer Patch Biosciences. Financial terms of the three acquisitions have not been disclosed, although Ginkgo did provide compensation information about grants of stock units for select employees of Patch Bio and Reverie Labs on its website. Proof Diagnostics has been working on developing a diagnostic system using CRISPR and other gene-editing technologies. In a statement, Ginkgo noted that Proof’s librari
Hence then, the article about ginkgo bioworks acquires 3 companies was published today ( ) and is available onTOP world News today ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details Finally We wish PressBee provided you with enough information of ( Ginkgo Bioworks acquires 3 companies )